Your browser doesn't support javascript.
loading
Early Elevated IFNα Identified as the Key Mediator of HIV Pathogenesis and its low level a Hallmark of Elite Controllers.
Le Buanec, Hélène; Schiavon, Valérie; Merandet, Marine; How-Kit, Alexandre; Bergerat, David; Fombellida-Lopez, Céline; Bensussan, Armand; Bouaziz, Jean-David; Burny, Arsène; Darcis, Gilles; Song, Hongshuo; Sajadi, Mohammad M; Kottilil, Shyamasundaran; Gallo, Robert C; Zagury, Daniel.
Afiliação
  • Le Buanec H; Université de Paris; INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010 Paris, France.
  • Schiavon V; Université de Paris; INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010 Paris, France.
  • Merandet M; Université de Paris; INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010 Paris, France.
  • How-Kit A; Laboratory for Genomics Foundation Jean Dausset-CEPH; Paris France.
  • Bergerat D; Université de Paris; INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010 Paris, France.
  • Fombellida-Lopez C; Laboratory of Infectious Diseases, GIGA-I3, GIGA-Institute University of Liege; 4000 Liege, Belgium.
  • Bensussan A; Université de Paris; INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010 Paris, France.
  • Bouaziz JD; Université de Paris; INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010 Paris, France.
  • Burny A; Dermatology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Darcis G; Laboratory of Molecular Biology, Gembloux Agrobiotech,University of Liège; Belgium.
  • Song H; Global Virus Network, Baltimore, MD 21201, USA.
  • Sajadi MM; Laboratory of Infectious Diseases, GIGA-I3, GIGA-Institute University of Liege; 4000 Liege, Belgium.
  • Kottilil S; Institute of Human Virology, School of Medicine, University of Maryland; Baltimore MD, 21201, USA, Department of Medicine, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
  • Gallo RC; Global Virus Network, Baltimore, MD 21201, USA.
  • Zagury D; Institute of Human Virology, School of Medicine, University of Maryland; Baltimore MD, 21201, USA, Department of Medicine, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Res Sq ; 2023 May 11.
Article em En | MEDLINE | ID: mdl-37215045
ABSTRACT
Advances in HIV therapy came from understanding its replication. Further progress toward "functional cure" -no therapy needed as found in Elite Controllers (EC)- may come from insights in pathogenesis and avoidance by EC. Here we show that all immune cells from HIV-infected persons are impaired in non-EC, but not in EC. Since HIV infects few cell types, these results suggest an additional mediator of pathogenesis. We identify that mediator as elevated pathogenic IFNα, controlled by EC likely by their preserved potent NK-cells and later by other killer cells. Since the earliest days of infection predict outcome genetic or chance events must be key to EC, and since we found no unique immune parameter at the onset, we suggest a chance infection with a lower HIV inoculum. These results offer an additional approach toward functional cure a judicious targeting of IFNα for all non-EC patients.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Revista: Res Sq Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Revista: Res Sq Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
...